Collegium Pharmaceutical
COLL
S$37.62
Share price
-1.20%
Change (1 day)
-14.87%
Change (1 year)
Categories
Collegium Pharmaceutical (COLL) - Total debt
Total debt on the balance sheet as of March 2025 : S$1.07 Billion
According to Collegium Pharmaceutical 's latest financial reports the company's total debt is S$1.07 Billion. A company’s total debt is the sum of all current and non-current debts.
Collegium Pharmaceutical - Total debt on balance sheet (from 2014 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | S$1.16 B | 31.16% |
| 2023-12-31 | S$0.89 B | -6.33% |
| 2022-12-31 | S$0.95 B | 171.78% |
| 2021-12-31 | S$0.34 B | -0.81% |
| 2020-12-31 | S$0.35 B | 1111.42% |
| 2019-12-31 | S$29.11 M | 85.3% |
| 2018-12-31 | S$15.71 M | 694.21% |
| 2017-12-31 | S$1.97 M | -67.03% |
| 2016-12-31 | S$6 M | -37.74% |
| 2015-12-31 | S$9.63 M | -43.93% |
| 2014-12-31 | S$17.18 M | 1294.15% |
| 2013-12-31 | S$1.23 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Agile Therapeutics
AGRX | S$0.36 M | -99.97% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | S$3.25 B | 202.94% | 🇮🇪 Ireland |
 United Therapeutics UTHR | S$0.25 B | -76.31% | 🇺🇸 USA |
 KemPharm KMPH | S$29.4 M | -97.26% | 🇺🇸 USA |